Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - ATMI LifeSciences

  • ATMI Supplies Bioreactor for Orgenesis, Takes $1.3M Stake
    platform is very suitable for adherent fragile cell culture applications, such as the adult liver cells," Mario Philips, svp and GM of ATMI LifeSciences, said in a statement. ...
    5-9-2013
  • GEN | Biolinks
    US AstraZeneca Asuragen Services ATCC ATMI ATR Biotech AusBiotech Australian Academy ... LifeScience Alley (Minnesota) LifeSciences British Columbia Ligand ...
  • Single-Use Bioreactor Roundup
    ... As mentioned before, the market is still young-it has only really been around for 10 to 12 years and still growing at a rate of about 20% or more. At ATMI LifeSciences, we believe ...
    4-15-2013
  • Scaling Up Stem Cells
    intense revalidation of cell integrity. ATMI LifeSciences developed the Xpansion(tm) bioreactor system to overcome these issues and enable stem cell culture scaleup ( Figure 1 ). ...
    1-15-2013
  • ATMI Buys Partner Artelis to Acquire Disposable Bioreactor Platform...
    to the life sciences market," comments Mario Phiips, svp and general manager at ATMI LifeSciences. "While they're still at an early stage from a commercial ramp standpoint, ...
    11-2-2010
  • ATMI Expands Biomanufacturing Facility
    In late July ATMI LifeSciences completed a two-year, $4.5 million, 4,000 sq. ft. expansion project for its Bloomington, MN, manufacturing facility. The site will serve as the North ...
    9-1-2010
  • Bioreactor and Fermentor Market Trends
    ... The company's application center works with customers to develop and optimize processes and to customize media for a client cell lines. ATMI LifeSciences plans to double its global ...
    8-1-2009
  • ATMI Acquires LevTech for $27M to Fortify Its Position as a Disposable...
    since 1987," points out Mario Philips, gm of ATMI LifeSciences. "Since 1999, growing customer demand has led us to extend our expertise to the biopharmaceutical industry. ...
    1-8-2008
  • Cultivating Anchorage-Dependent Cells
    Recently, ATMI LifeSciences (www.atmi-lifesciences.com), Artelis (www.artelis.be), and Pierre-Guerin Biolafitte (www.biolafitte.com) teamed up to develop scalable, disposable ...
    9-15-2007
  • Disposable Bioreactors Gaining Favor
    ... Last month, ATMI Life Sciences (www.atmi-lifesciences) and Pierre Guerin-SAS (www.pierreguerin.com) formed an alliance to design, manufacture, and market disposable fermentors and ...
    6-15-2006

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll